PET-CT Based Radiotherapy in Esophageal Cancer Patients

Consequences of Positron-Emission-Tomography/Computed Tomography (PET/CT) Based Radiotherapy Treatment Planning for Clinical Outcome in Esophageal Cancer Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01156831

Enrollment

115

Registered

2010-07-05

Start date

2007-11-30

Completion date

2013-05-31

Last updated

2014-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal Neoplasms

Keywords

Esophageal cancer, PET-CT planning

Brief summary

The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients.

Detailed description

The purpose of this study is to determine the locoregional control in PET/CT based radiotherapy treatment planning in the treatment of esophageal cancer patients

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Histologically proven adenocarcinoma or squamous cell carcinoma of the esophagus * Local curable disease able to undergo Chemoradiotherapy.

Exclusion criteria

* Metastasized disease. * Previous or concurrent malignancies.

Design outcomes

Primary

Measure	Time frame
Locoregional control	2 years and 5 years

Secondary

Measure	Time frame	Description
Overall Survival	2 years and 5 years	—
Disease Free survival	2 years and 5 years	—
Tumor regression grade	At the time of surgery	Tumor regression grade at time of surgery evaluated by pathologist.

Countries

Netherlands

Outcome results